CEO Anne Wojcicki announced today that 23andMe is working with drug maker GlaxoSmithKline (GSK) to develop new drugs and treatments with help from all that genetic data the company has on file.
The post 23andMe, GlaxoSmithKline Will Use Your DNA to Develop New Drugs appeared first on ExtremeTech.
No comments:
Post a Comment